elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30896811-0017A4C9-5013-436E-A8F8-09A5BD0A3F8E
Q30896811-0017A4C9-5013-436E-A8F8-09A5BD0A3F8E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30896811-0017A4C9-5013-436E-A8F8-09A5BD0A3F8E
Specialization of tumour vasculature.
P2860
Q30896811-0017A4C9-5013-436E-A8F8-09A5BD0A3F8E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30896811-0017A4C9-5013-436E-A8F8-09A5BD0A3F8E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ac4a094685ba5235adb6a3c3cd91fffab23c0945
P2860
Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).